Drug intelligence / Profile preview

Yanshikang Granules

Development stage: Unknown
Lead developer: Jiuhua Huayuan Group Pharmaceutical
Administration: Oral

Overview

Yanshikang Granules is a traditional Chinese medicine (TCM) formulation developed and marketed by Anhui Jiuhua Huayuan Pharmaceutical. It is an oral granule preparation that has received marketing approval in China. While the specific herbal composition and molecular targets are not publicly detailed in English-language pharmaceutical databases, the product's name—specifically the character 'Yan' (咽), which refers to the throat or pharynx—indicates its primary therapeutic use for throat-related conditions such as pharyngitis or throat inflammation. As a TCM product, it likely functions through the synergistic effects of multiple botanical extracts to alleviate symptoms of respiratory or pharyngeal discomfort.

Brand names: Yanshikang
Other names: Yanshikang Keli咽石康颗粒

Beyond the preview

Go deeper on Yanshikang Granules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Yanshikang Granules.

Explore the full profile